Pennsylvania 2025-2026 Regular Session

Pennsylvania House Bill HB2158

Introduced
1/26/26  

Caption

Further providing for schedules of controlled substances.

Impact

The discussions surrounding HB 2158 highlight the ongoing struggle to balance public health and safety with the needs of individuals who may require certain controlled substances for legitimate medicinal purposes. Supporters argue that the proposed changes will enhance the state's ability to combat the illegal drug trade and better regulate substances that may lead to addiction. They believe that a more precise classification system will empower law enforcement and public health officials to respond effectively to substance misuse and related crimes. Conversely, opponents raise concerns that the bill could inadvertently restrict access to necessary medications for those in need, thereby affecting patient care and treatment options.

Summary

House Bill 2158 is focused on the further regulation and scheduling of controlled substances. The bill aims to provide greater clarity and consistency in the classification of various substances that are deemed to pose a risk to public health and safety. By refining the schedules of controlled substances, the bill intends to ensure that law enforcement and health agencies have clear guidelines for managing these substances, ultimately contributing to better public safety outcomes. The proposal has sparked discussions regarding its potential implications for medical use, accessibility for patients, and its impact on addiction treatment programs.

Contention

Notable points of contention regarding HB 2158 center on the potential consequences of reclassifying certain controlled substances. Critics argue that changing schedules could lead to unintended barriers for patients requiring certain treatments, particularly in the context of chronic pain management or mental health interventions. Additionally, there is concern among healthcare providers and advocacy groups about whether the bill adequately addresses the complexities of substance use disorders and addiction treatment. Stakeholders are urging that any legislative measures should preserve access to care for individuals struggling with these issues while still ensuring public safety.

Companion Bills

No companion bills found.

Previously Filed As

PA SB899

Further providing for schedules of controlled substances.

PA SB946

Further providing for schedules of controlled substances and providing for tianeptine-related adverse health events.

PA SB866

Further providing for schedules of controlled substances and for secure storage of xylazine; and adding provisions relating to medetomidine.

PA SB0716

Controlled substances: schedules; scheduling of certain controlled substances; modify. Amends sec. 7204 of 1978 PA 368 (MCL 333.7204).

PA HB5162

Controlled substances: schedules; scheduling of certain controlled substances; modify. Amends sec. 7204 of 1978 PA 368 (MCL 333.7204).

PA HB563

Controlled substances; provide for automatic scheduling of psilocybin after federal scheduling.

PA SB2056

Controlled substances; provide for automatic scheduling of certain substance if federal scheduling occurs.

PA HB417

Uniform Controlled Substances Act; include five substances in Schedule I.

PA SB2064

The scheduling of controlled substances; and to declare an emergency.

PA HB3767

Controlled dangerous substances; adding certain substances to Schedules I and IV; effective date.

Similar Bills

No similar bills found.